Recombinant TNFSF4 (Oxelumab Biosimilar) antibody
Reactivity: Human
FACS, Func, BLI, ELISA, SPR
Host: Human
Monoclonal
unconjugated
Recombinant Antibody
-
- Target See all TNFSF4 (Oxelumab Biosimilar) products
- TNFSF4 (Oxelumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Human
- Expression System
- CHO Cells
-
Clonality
- Monoclonal
-
Conjugate
- This TNFSF4 (Oxelumab Biosimilar) antibody is un-conjugated
- Application
- Flow Cytometry (FACS), Functional Studies (Func), Bio-Layer Interferometry (BLI), ELISA, Surface Plasmon Resonance (SPR)
- Purpose
- Anti-TNFSF4 / OX40L / CD252 Reference Antibody (oxelumab)
- Sequence
- EVQLLESGGG LVQPGGSLRL SCAASGFTFN SYAMSWVRQA PGKGLEWVSI ISGSGGFTYY ADSVKGRFTI SRDNSRTTLY LQMNSLRAED TAVYYCAKDR LVAPGTFDYW GQGALVTVSS ASTKGPSVFP LAPSSKSTSG GTAALGCLVK DYFPEPVTVS WNSGALTSGV HTFPAVLQSS GLYSLSSVVT VPSSSLGTQT YICNVNHKPS NTKVDKKVEP KSCDKTHTCP PCPAPELLGG PSVFLFPPKP KDTLMISRTP EVTCVVVDVS HEDPEVKFNW YVDGVEVHNA KTKPREEQYN STYRVVSVLT VLHQDWLNGK EYKCKVSNKA LPAPIEKTIS KAKGQPREPQ VYTLPPSRDE LTKNQVSLTC LVKGFYPSDI AVEWESNGQP ENNYKTTPPV LDSDGSFFLY SKLTVDKSRW QQGNVFSCSV MHEALHNHYT QKSLSLSPG,DIQMTQSPSS LSASVGDRVT ITCRASQGIS SWLAWYQQKP EKAPKSLIYA ASSLQSGVPS RFSGSGSGTD FTLTISSLQP EDFATYYCQQ YNSYPYTFGQ GTKLEIKRTV AAPSVFIFPP SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
- Characteristics
- Anti-TNFSF4 / OX40L / CD252 Reference Antibody (oxelumab) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
- Purity
- >95 %
- Isotype
- IgG1
-
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Comment
-
Therapeutic Agents by Target and Mechanism: OX40L inhibitors
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Concentration
- 1 mg/mL
- Buffer
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
- Storage
- 4 °C,-80 °C
- Storage Comment
- +4°C,-80°C
-
- Target
- TNFSF4 (Oxelumab Biosimilar)
- Abstract
- TNFSF4 (Oxelumab Biosimilar) Products
- Target Type
- Biosimilar
- Molecular Weight
- 145.5 kDa
- UniProt
- P23510
-
You are here:
